Taiwan FDA registration a99291cf666bbb17596cab853a1d4c6c

"Kabi" Aimeko Blood Separation Set

TW: “卡比”愛美可血液分離套組

Taiwan·Risk Class 2·Fresenius Kabi AG;; Fenwal International, Inc.·Registered Jun 07, 2018 – Jun 07, 2028Active

Registration details

Analysis ID: a99291cf666bbb17596cab853a1d4c6c
Customs Code: DHA05603114107

Company information

Manufacturer: Fresenius Kabi AG;; Fenwal International, Inc.
Manufacturer Country: Dominican Republic;;Germany
Authorized Representative: FRESENIUS KABI TAIWAN LIMITED

Product details

Intended Use: This product can only be used with the AmiCORE Blood Fractionator for the collection of reduced leukoapheresis platelets (LRAP).
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.9100 Containers for the collection and disposal of blood and blood components
Import Information: import

Dates and status

Registration Date: Jun 07, 2018
Expiry Date: Jun 07, 2028

About this record

Access comprehensive regulatory information for "Kabi" Aimeko Blood Separation Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a99291cf666bbb17596cab853a1d4c6c and manufactured by Fresenius Kabi AG;; Fenwal International, Inc.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.